TKI-associated proteinuria and nephrotic syndrome : a narrative review with clinical illustration in radio-iodine-refractory thyroid cancer
Bron
Acta clinica Belgica - ISSN 1784-3286- (2026) p.
PARP and androgen-signaling inhibition plus ADT in metastatic prostate cancer
Bron
The New England journal of medicine - ISSN 0028-4793- (2026) p.
Perioperative enfortumab vedotin and pembrolizumab in bladder cancer
Bron
The New England journal of medicine - ISSN 0028-4793-394:13 (2026) p. 1257-1269
First-line lenvatinib plus pembrolizumab versus chemotherapy for advanced endometrial cancer : 1-Year follow-up after final analysis of the ENGOT-en9/LEAP-001 phase 3 trial
Bron
International journal of gynecological cancer - ISSN 1048-891X-36:1 (2026) p. 1-7
A plain language summary of the TROPiCS-04 study : sacituzumab govitecan use after platinum-based chemotherapy and immunotherapy in people with locally advanced or metastatic cancer of the bladder, urethra, or upper urinary tract
Bron
Future oncology - ISSN 1479-6694-21:28 (2025) p. 3593-3610